VIRI
Price:
$0.178
Market Cap:
$4.94M
Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It is also developing IMC-2, a combination of valacyclovir and celecoxib for the treatment of managing the fatigue, sleep, attention, pain, autonomic function, and anxiety associated with long COVID. The company was formerly known as Virios Therapeutics, LLC and changed its name to Virios Therapeutics, Inc. in December 2020. Virios Therapeutics, Inc. was founded in 2012 and i...[Read more]
Industry
Biotechnology
IPO Date
2020-12-17
Stock Exchange
NASDAQ
Ticker
VIRI
According to Virios Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.74. This represents a change of -68.70% compared to the average of -2.36 of the last 4 quarters.
The mean historical PE Ratio of Virios Therapeutics, Inc. over the last ten years is -16.52. The current -0.74 PE Ratio has changed 347.83% with respect to the historical average. Over the past ten years (40 quarters), VIRI's PE Ratio was at its highest in in the September 2022 quarter at -0.34. The PE Ratio was at its lowest in in the March 2020 quarter at -43.27.
Average
-16.52
Median
-4.35
Minimum
-49.99
Maximum
-0.21
Discovering the peaks and valleys of Virios Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 850.46%
Maximum Annual PE Ratio = -0.21
Minimum Annual Increase = -91.97%
Minimum Annual PE Ratio = -49.99
Year | PE Ratio | Change |
---|---|---|
2023 | -2.04 | 850.46% |
2022 | -0.21 | -91.97% |
2021 | -2.67 | -55.68% |
2020 | -6.03 | -87.94% |
2019 | -49.99 | 30.84% |
The current PE Ratio of Virios Therapeutics, Inc. (VIRI) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-1.64
5-year avg
-12.19
10-year avg
-16.52
Virios Therapeutics, Inc.’s PE Ratio is less than SeaStar Medical Holding Corporation (-0.46), less than ZyVersa Therapeutics, Inc. (-0.10), less than Sonnet BioTherapeutics Holdings, Inc. (-0.55), less than Revelation Biosciences, Inc. (-0.09), less than eFFECTOR Therapeutics, Inc. (-0.00), greater than Zura Bio Limited (-9.00), less than Navidea Biopharmaceuticals, Inc. (0.03), greater than Immix Biopharma, Inc. (-2.98), less than CNS Pharmaceuticals, Inc. (-0.00), less than Altamira Therapeutics Ltd. (-0.03), less than Phio Pharmaceuticals Corp. (-0.15), less than TransCode Therapeutics, Inc. (-0.10),
Company | PE Ratio | Market cap |
---|---|---|
-0.46 | $20.29M | |
-0.10 | $2.70M | |
-0.55 | $4.53M | |
-0.09 | $1.43M | |
-0.00 | $188.18K | |
-9.00 | $230.86M | |
0.03 | $100.08K | |
-2.98 | $54.08M | |
-0.00 | $4.60M | |
-0.03 | $2.04M | |
-0.15 | $2.25M | |
-0.10 | $4.56M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Virios Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Virios Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Virios Therapeutics, Inc.'s PE Ratio?
How is the PE Ratio calculated for Virios Therapeutics, Inc. (VIRI)?
What is the highest PE Ratio for Virios Therapeutics, Inc. (VIRI)?
What is the 3-year average PE Ratio for Virios Therapeutics, Inc. (VIRI)?
What is the 5-year average PE Ratio for Virios Therapeutics, Inc. (VIRI)?
How does the current PE Ratio for Virios Therapeutics, Inc. (VIRI) compare to its historical average?